Rifampin
12 NDCs across 5 manufacturers|12 Generic,0 Brand
Rifampin is used to treat aids-related opportunistic infections, brucellosis, haemophilus infections, legionnaires' disease, leprosy and bacterial meningitis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved May 28, 1997. FDA's Orange Book lists 9 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $7 million on Rifampin across 112,000 claims for 40,000 beneficiaries.
Rifampin is available as 12 NDCs from 5 manufacturers (12 generic, 0 brand), with NADAC prices from $0.68 to $0.90 per EA — a 32% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Active FDA drug shortage
12 Rifampin presentations are currently listed in FDA's drug shortage database (first posted Feb 17, 2021). Shortages can move NADAC prices in the following weeks.
Total NDCs
12
12G / 0B
Manufacturers
5
competing in market
Price Spread
$0.68 – $0.90
per EA
7d Activity
avg +4.6% WoW · of 12 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Epic Pharma LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Rifamycin Antibacterial class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
5 manufacturers producing RIFAMPIN
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
RIFAMPIN 150 MG CAPSULE | $0.8978 per EA | +11.73% |
RIFAMPIN 150 MG CAPSULE | $0.8978 per EA | +11.73% |
RIFAMPIN 150 MG CAPSULE | $0.8978 per EA | +11.73% |
RIFAMPIN 150 MG CAPSULE | $0.8978 per EA | +11.73% |
RIFAMPIN 300 MG CAPSULE | $0.6802 per EA | — |
RIFAMPIN 300 MG CAPSULE | $0.6802 per EA | — |
RIFAMPIN 300 MG CAPSULE | $0.6789 per EA | -0.19% |
RIFAMPIN 300 MG CAPSULE | $0.6789 per EA | -0.19% |
RIFAMPIN 300 MG CAPSULE | $0.6789 per EA | -0.19% |
RIFAMPIN 300 MG CAPSULE | $0.6789 per EA | -0.19% |
RIFAMPIN 300 MG CAPSULE | $0.6789 per EA | -0.19% |
RIFAMPIN 300 MG CAPSULE | $0.6789 per EA | -0.19% |
Frequently Asked Questions
What is Rifampin used to treat?
Rifampin is used to treat aids-related opportunistic infections, brucellosis, haemophilus infections, legionnaires' disease, leprosy and bacterial meningitis, per the National Library of Medicine's MED-RT classification.
When did Rifampin become available as a generic?
FDA approved the first generic Rifampin (ANDA) on May 28, 1997. The Orange Book currently lists 9 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Rifampin?
In 2024, Medicare Part D spent $7 million on Rifampin across 112,000 claims for 40,000 beneficiaries.
Is Rifampin in shortage?
Yes — FDA's drug shortage database currently lists 12 Rifampin presentations with status "Current", first posted Feb 17, 2021.
How many Rifampin products are on the market?
The Rifampin drug market contains 12 NDCs from 5 manufacturers — 12 generic and 0 brand products.
What is the price range for Rifampin?
NADAC reference prices for Rifampin range from $0.6789 to $0.8978 per EA — a 32% difference between cheapest and most expensive.
Which manufacturers make Rifampin?
5 manufacturers list Rifampin in NADAC. Ranked by number of NDCs, the largest are Epic Pharma LLC (4), Lupin Pharmaceuticals Inc. (3), PuraCap Laboratories LLC (2), American Health Packaging (2), Major Pharmaceuticals (1).
How has the price of Rifampin changed recently?
Over the past 7 days, 4 Rifampin NDCs rose and 6 fell, with a market-wide average change of +4.6%.